BioSpace News Archive

Cannabis Science and Technology® a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction and cultivation, is excited to announce the lineup of speakers for its first Hemp Science & Technology Virtual Symposium.

Praetego Inc (https://www.praetego.com/), a preclinical stage pharmaceutical company committed to improving health outcomes for patients living with diabetes, is pleased to announce the approval of a 3 year $2.1M STTR grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.

Leading diabetes scientist Debbie C. Thurmond, Ph.D., has been named the new director of City of Hope’s Diabetes & Metabolism Research Institute, which continues diabetes research at City of Hope that was started more than 70 years ago.

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the PerkinElmer Signals™ Notebook and PerkinElmer Signals™ Medical Review SaaS solutions have been granted SOC 2 Level 1 Attestation for the American Institute of Certified Public Accountants (AICPA’s) Trust Service Principles of Security, Confidentiality and Availability.

The 2nd Annual HealthTech Summit, hosted by IntuitiveX, is a rare opportunity for life science entrepreneurs and startups to gain insider information on how to successfully take their company to the next level without losing momentum.

The wearable sensor industry will be worth $2.5 billion in 2020, having tripled in size since 2014.

Aerus ActivePure Air and Surface Purifier Provides 99.98% SARS-CoV-2 Surface Reduction Rate in Controlled, Independent Laboratory Studies

Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions to support the entire clinical development process, today announced that it has for the second year in a row been named a Leader in the “Clinical Development Platform Vendors PEAK Matrix® Assessment 2020” by Everest Group.

LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ION373 for the treatment of people with Alexander disease, a severe,